BEDFORD, N.H. — Babies are born with tumors on their brains, and they’re often treated with chemotherapy.
But when it comes to benign brain cancer, the treatment has been evolving in recent years, leading some experts to question the safety of drugs currently used to treat tumors.
The World Health Organization says more than half of the people who die from the disease are diagnosed after they’re 50.
There’s no cure, and treatments often don’t work and doctors say that if patients have the tumor removed, it can lead to other complications.
Experts say the biggest concern is the spread of the tumor to the brain.
A study released this week by the American College of Neurosurgeons says some of the drugs used to slow the spread are not effective at killing tumors, and some doctors are calling for new options.
“There are new drugs that may be able to kill tumors, but they don’t yet have FDA approval to do so, and so that’s why I think it’s important to take a step back and consider what we can do now to improve treatment of benign brain cancers,” said Dr. Stephen C. Burd, director of neurosurgery at Children’s Hospital of Philadelphia.
It’s a problem the American Cancer Society says has been exacerbated by a surge in benign brain tumours.
They have more than tripled in the past two years, according to the American Association of Neurological Surgeons.
More: Burd says the new research is just one piece of the puzzle.
New treatments for brain tumors: New drugs are helping to slow their spread and stop the spread to other parts of the body, he said.
One of those new drugs is a new drug called naloxone, which has been shown to reduce the spread in laboratory tests.
But the drug hasn’t been used on a large scale yet, so scientists have been trying to find a way to stop the tumors from spreading to other organs.
Burd says there’s also hope that the new drugs could help treat more than one tumor.
We have a lot of promising drugs in the pipeline that will do some of those things, but we need to go further,” he said, adding that his group is working with the National Institute of Neurologic Disorders and Stroke to develop drugs to treat different types of tumors.”
It’s really the combination of the right combination of treatments that will lead to an effective treatment,” he told ABC News.
Dr. Robert K. Bock, a pediatric neurosurgeon at the University of California, San Francisco, said the problem is that the drugs are designed to kill certain types of cancer cells, and it’s not clear whether they can kill the tumors themselves.
This is one of the first studies to look at a drug that could kill brain tumors, which could lead to a better understanding of how it works and its potential impact on patients, Bock said.